- Adastra Holdings Ltd (CSE:XTRX,FRA:D2EP) is a leading licensed Canadian agricultural-scale cannabis extraction, distillation, product manufacturer and retailer.
- Adastra’s newly commissioned hydrocarbon extractor has increased the extraction capacity of its facility by up to 146,000 kgs per year (agricultural scale) making them one of the largest full-service cannabis extraction companies in Canada.
- Formerly Adastra Labs, the company is one of the most recognized cannabis brands and its [award winning] shatter and vape products are widely distributed in 1,400 retailers across Canada.
- Adastra’s flagship Shatter product line is unique in the Canadian marketplace and has the potential to be a significant driver of growth. Shatter is a high potency and high purity wax and crumble cannabis concentrate.
- Adastra received its Health Canada R&D license to conduct in-house human testing for various cannabis products.
- The company operates with an attractive financial model that has the potential to generate strong returns for shareholders. The company aims to further increase revenues by launching over a dozen new product lines and white label products.
- The company is led by a highly experienced management team, including cannabis industry pioneers and Ph.D. experts in plant medicine and plant biochemistry.
- Adastra signed a definitive agreement with Sitka Weed Works Inc. regarding the supply of premium craft cannabis grown by Sitka.
Adastra Holdings Ltd (CSE:XTRX,FRA:D2EP) is a licensed Canadian agricultural-scale cannabis extraction, distillation, product manufacturer, and retailer. Formerly known as Phyto Extractions Inc., the company is one of the best-known brands in the Canadian cannabis market. Its popular vapes, concentrates, and oil products are widely available at 1,400 retailers across Canada.
The company competes in the highly attractive worldwide cannabis market, The company competes in the highly attractive worldwide cannabis market, estimated to reach a value of US$50,251 million in 2021 and is expected to grow at a CAGR of 26.5 percent from 2021 to 2030.
In addition to medical cannabis use, recreational use is on the rise as markets in countries like Canada have opened through regulation in recent years. Critical factors for success in this market include the ability to navigate the complex regulatory landscape, access to supply, manufacturing and processing capability, and strong consumer brands.
Adastra operates through three businesses: